Austria
Croma-Pharma GmbH, founded by a pharmacist couple, is a distinguished name in the global minimally invasive aesthetics market. This Austrian family-owned business is recognized for its leadership in manufacturing premium quality hyaluronic acid syringes, alongside a comprehensive product portfolio that includes botulinum toxin, fillers, lifting threads, and biostimulators.
Operating with headquarters in Austria, Croma-Pharma boasts 550 employees and 13 subsidiaries across Europe and Brazil, bolstered by two joint ventures. The company’s distribution network extends through 60 exclusive export partners, engaging 80 markets worldwide, ranging from the US and Canada to China, Australia, and New Zealand.
Apart from its robust aesthetics line, the company also operates as a contract manufacturer in orthopaedics and ophthalmology. By investing in Croma-Pharma, investors gain access to a firm deeply rooted in innovation and global market presence, poised for growth in the expanding aesthetics industry.
